Phosphodiesterase 4 D gene polymorphism in relation to intracranial and extracranial atherosclerosis in ischemic stroke

Disease Markers

Volumn 31, Issue 4, 2011, Pages 191-197

  Kalita, Jayantee ^a   Somarajan, Bindu I ^a   Kumar, Bishwanath ^a   Kumar, Sunil ^a   Mittal, Balraj ^a   Misra, Usha K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

atherosclerosis; gene polymorphism; Ischemic stroke

Indexed keywords

PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 81055133454     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0810     Document Type: Article

References (27)

1. A. Callow, J. Moran, P. Kahn and R. Deterling, Human atherosclerosis: Vascular surgeon's viewpoint, Ann NY Acad Sci 149 (1968), 974-988.
2. E. Feldmann, N. Daneault, E. Kwan, K.J. Ho, M.S. Pessin, P. Langenberg and L.R. Caplan, Chinese-white differences in the distribution of occlusive cerebrovascular disease, Neurology 40 (1990), 1541-1545. (Pubitemid 20351346)
3. H.M. Liu, Y.K. Tu, P.K. Yip and C.T. Su, Evaluation of extracranial and intracranial carotid steno-occlusive diseases in Taiwan-Chinese patients with MR angiography: preliminary experience, Stroke 30 (1996), 282-286.
4. G. Kumar, J. Kalita, B. Kumar, V. Bansal, S.K. Jain and U.K. Misra, Magnetic resonance angiography findings in patients with ischemic stroke from North India, J Stroke Cerebrovasc Dis 19 (2010), 146-152.
5. S.J. Lee, S.J. Cho, H.S. Moon, Y.M. Shon, K.H. Lee, D.I. Kim, B.B. Lee, H.S. Byun, S.H. Han and C.S. Chung, Combined extracranial and intracranial atherosclerosis in Korean patients, Arch Neurol 60 (2003), 1561-1564. (Pubitemid 37443121)
6. R.L. Sacco, J.K. Roberts, B. Boden-Albala, Q. Gu, I.F. Lin, D.E. Kargman, L. Berglund, W.A. Hauser, S. Shea and M.C. Paik, Race-ethnicity and determinants of carotid atherosclerosis in a multiethnic population. The Northern Manhattan Stroke Study, Stroke 289 (1997), 29-935.
7. M.V. Padma, S. Gaikwad, S. Jain, M.C.Maheshwari and N.K. Misra, Distribution of vascular lesions in ischaemic stroke: A magnetic resonance angiographic study, Natl Med J India 10 (1997), 217-220. (Pubitemid 127555821)
8. D. Woo, R. Kaushal, B. Kissela, P. Sekar, M. Wolujewicz, P. Pal, K. Alwell, M. Haverbusch, I. Ewing, R. Miller, D. Kleindorfer, M. Flaherty, R. Chakraborty, R. Deka and J. Broderick, Association of Phosphodiesterase 4D with ischemic stroke: A population-based case-control study, Stroke 37(2) (2006), 371-376. (Pubitemid 43731989)
9. Y.C. Liao, H.F. Lin, Y.C. Guo, M.L. Yu, C.K. Liu and S.H. Juo, Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis, BMC Med Genet 11 (2010), 93.
10. J. Banerjee, V. Gupta, T. Ahmad, M. Faizaan, P. Agarwal and S. Ganesh, Inflammatory system gene polymorphism and the risk of stroke: A case control study in an Indian population, Brain Research Bulletin 75 (2008), 158-165. (Pubitemid 350297655)
11. M.D. Houslay and G. Milligan, Tailoring cAMP signaling responses through isoform multiplicity, Trends Biochem Sci 22 (1997), 217-224. (Pubitemid 27246638)
12. H.P. Adams, Jr., B.H. Bendixen, L.J. Kappelle, J. Biller, B.B. Love, D.L.Gordon and E.E.Marsh, 3rd, Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, 24 (1993), 35-41. (Pubitemid 23014379)
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA 285 (2001), 2486-2497.
14. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis, N Engl J Med 325 (1991), 445-453.
15. S.A.Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucl Acids Res 16(3) (1988), 1215.
16. D. Saleheen, S. Bukhari, S.R. Haider, A. Nazir, S. Khanum, S. Shafqat, M.K. Anis and P. Frossard, Association of phosphodiesterase 4d gene with ischemic stroke in a Pakistani population, Stroke 36 (2005), 2275-2277. (Pubitemid 41429259)
17. S. Gretarsdottir, G. Thorleifsson, S.T. Reynisdottir et al., The gene encoding phosphodiesterase 4D confers risk of ischemic stroke, Nat Genet Oct 35(2) (2003), 131-138. (Pubitemid 37187631)
18. H. Xue, H.Wang, X. Song,W. Li, K. Sun,W. Zhang, X.Wang, Y. Wang and R. Hui, Phosphodiesterase 4D gene polymorphism is associated with ischaemic and haemorrhagic stroke, Clin Sci (Lond) 116(4) (2009), 335-340.
19. S. Bevan, L. Porteous, M. Sitzer and H.S. Markus, Phosphodiesterase 4D gene ischemic stroke and asymptomatic carotid atherosclerosis, Stroke 36(5) (2005), 949-953. (Pubitemid 40629282)
20. E. Lohmussaar, A. Gschwendtner, J.C. Mueller, T. Org, E. Wichmann, G. Hamann, T. Meitinger and M. Dichgans, Alox5AP gene and the PDE4D gene in a central European population of stroke patients, Stroke 36 (2005), 731-736.
21. M.-S.Hsieh, S.-C. Yu,W.-T. Chung, Y.-M. Hsueh, F.-C. Chen, W.-T. Chiu and H.-M. Lee, Phosphodiesterase 4D (PDE4D) Gene Variants and Risk of Ischemic Stroke in the Taiwanese Population Lab medicine 40(2) (2009), 87-90.
22. R.Y. Zee, V.H. Brophy, S. Cheng, H.H. Hegener, H.A. Erlich and P.M.Ridker, Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: A prospective, nested case-control evaluation, Stroke 37(8) (2006), 2012-2017. (Pubitemid 44309896)
23. V.H. Brophy, S.K. Ro, B.K. Rhees et al., Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a U.S. population stratified by hypertension status, Stroke 37 (2006), 1385-1390. (Pubitemid 44305714)
24. A. Munshi,M.S.Babu, S. Kaul, G. Shafi, A.N.Anila, S.Alladi and A. Jyothy, Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population, J Neurol Sci Oct 15 285 (2009), 142-145.
25. J.M. Staton, M.S. Sayer, G.J. Hankey, J. Attia, A. Thakkinstian, Q. Yi, V.J. Cole, R. Baker and J.W. Eikelboom, Association between phosphodiesterase 4D gene and ischaemic stroke, J Neurol Neurosurg Psychiatry 77 (2006), 1067-1069. (Pubitemid 44338532)
26. J.C. Stoclet, T. Keravis, N. Komas and C. Lugnier, Cyclic nucleotide phophodiesterases as therapeutic targets in cardiovascular diseases, Expert Opin Investig Drugs 4 (1995), 1081C- 1100C.
27. S. Birk, L. Edvinsson, J. Olesen and C. Kruuse, Analysis of the effects of phosphodiesterase type 3 and 4 inhibitors in cerebral arteries, Eur J Pharmacol 489 (2004), 93-100. (Pubitemid 38520076)